High-sensitivity C-reactive protein levels and pregnancy outcomes in women with unexplained infertility after ovarian stimulation with intrauterine insemination in a multicenter trial

Sarah Z Gavrizi, Sushila Arya, Jennifer D Peck, Jennifer F Knudtson, Michael P Diamond, Robert A Wild, Karl R Hansen, Sarah Z Gavrizi, Sushila Arya, Jennifer D Peck, Jennifer F Knudtson, Michael P Diamond, Robert A Wild, Karl R Hansen

Abstract

Objective: To determine if chronic inflammation, assessed by basal high-sensitivity C-reactive protein (hs-CRP) levels, is associated with pregnancy outcomes in women with unexplained infertility undergoing ovarian stimulation with intrauterine insemination.

Design: Prospective cohort analysis of the Reproductive Medicine Network's Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) randomized controlled trial.

Setting: Multicenter university-based randomized controlled trial.

Patients: A total of 781 couples with unexplained infertility.

Interventions: Secondary analysis.

Main outcome measures: Adjusted risk ratios of live birth, clinical pregnancy, and pregnancy loss rates by hs-CRP levels.

Results: Associations between hs-CRP levels and clinical pregnancy rates were not observed after adjustment for baseline body mass index. There were fewer live births among women with higher hs-CRP levels, although confidence intervals crossed 1.0. The risk of pregnancy loss was greater in women with increased hs-CRP levels (1-3 mg/L: risk ratio [RR], 1.67; 95% confidence interval [CI], 1.00-2.79; >3-10 mg/L: RR, 1.84; 95% CI, 1.06-3.20; and >10 mg/L: RR, 2.14; 95% CI, 1.05-4.36 compared to women with hs-CRP <1 mg/L).

Conclusions: This investigation suggests that chronic inflammation may increase the risk of pregnancy loss but not impact the clinical pregnancy rate in women with unexplained infertility undergoing ovarian stimulation with intrauterine insemination. Associations between inflammation and pregnancy outcomes in women with infertility merit further investigation.

Clinical trial registration number: clinicaltrials.gov NCT01044862.

Keywords: Unexplained infertility; high-sensitivity C-reactive protein; live birth; ovarian stimulation; pregnancy loss.

© 2022 Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.

References

    1. Practice Committee of the American Society for Reproductive Medicine Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113:305–322.
    1. Radin R.G., Sjaarda L.A., Silver R.M., Nobles C.J., Mumford S.L., Perkins N.J., et al. C-reactive protein in relation to fecundability and anovulation among eumenorrheic women. Fertil Steril. 2018;109:232–239.e1.
    1. Sjaarda L.A., Radin R.G., Swanson C., Kuhr D.L., Mumford S.L., Galai N., et al. Prevalence and contributors to low-grade inflammation in three US populations of reproductive age women. Paediatr Perinat Epidemiol. 2018;32:55–67.
    1. Pennells L., Kaptoge S., Wood A., Sweeting M., Zhao X., White I., et al. Emerging risk factors collaboration. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019;40:621–631.
    1. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979.
    1. Vodolazkaia A., Bossuyt X., Fassbender A., Kyama C.M., Meuleman C., Peeraer K., et al. A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis. Reprod Biol Endocrinol. 2011;9:113.
    1. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671–674.
    1. Boulman N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O., Blumenfeld Z. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2160–2165.
    1. Schisterman E.F., Silver R.M., Lesher L.L., Faraggi D., Wactawski-Wende J., Townsend J.M., et al. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet. 2014;384:29–36.
    1. Naimi A.I., Perkins N.J., Sjaarda L.A., Mumford S.L., Platt R.W., Silver R.M., et al. The effect of preconception-initiated low-dose aspirin on human chorionic gonadotropin-detected pregnancy, pregnancy loss, and live birth: per protocol analysis of a randomized trial. Ann Intern Med. 2021;174:595–601.
    1. Sjaarda L.A., Radin R.G., Silver R.M., Mitchell E., Mumford S.L., Wilcox B., et al. Preconception low-dose aspirin restores diminished pregnancy and live birth rates in women with low-grade inflammation: a secondary analysis of a randomized trial. J Clin Endocrinol Metab. 2017;102:1495–1504.
    1. Diamond M.P., Legro R.S., Coutifaris C., Alvero R., Robinson R.D., Casson P., et al. NICHD Reproductive Medicine Network. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373:1230–1240.
    1. Diamond M.P., Legro R.S., Coutifaris C., Alvero R., Robinson R.D., Casson P., et al. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics. Fertil Steril. 2015;103:962–973.e4.
    1. Landy H.J., Keith L.G. The vanishing twin: a review. Hum Reprod Update. 1998;4:177–183.
    1. Myers G.L., Rifai N., Tracy R.P., Roberts W.L., Alexander R.W., Biasucci L.M., et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation. 2004;110:e545–e549.
    1. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., III, Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.
    1. Hansen K.R., He A.L.W., Styer A.K., Wild R.A., Butts S., Engmann L., et al. Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertil Steril. 2016;105:1575–1583.e2.
    1. Brouillet S., Boursier G., Anav M., Du Boulet De La Boissiere B., Gala A., Ferrieres-Hoa A., et al. C-reactive protein and ART outcomes: a systematic review. Hum Reprod Update. 2020;26:753–773.
    1. Gaskins A.J., Wilchesky M., Mumford S.L., Whitcomb B.W., Browne R.W., Wactawski-Wende J., et al. Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol. 2012;175:423–431.
    1. Zipf G., Chiappa M., Porter K.S., Ostchega Y., Lewis B.G., Dostal J. National health and nutrition examination survey: plan and operations, 1999-2010. Vital Health Stat 1. 2013;56:1–37.
    1. Sahin A., Engin-Ustun Y., Tokmak A., Sahin H., Erkaya S., Ozgu-Erdinc A.S. Serum levels of transforming growth factor beta1 and C-reactive protein as possible markers of intra uterine insemination outcome. Eur Cytokine Netw. 2018;29:121–126.
    1. Tasdemir N., Sahin A., Celik C., Abali R., Guzel S., Uzunlar O., et al. Evaluation of human chaperonin 10 and high-sensitivity C-reactive protein levels of infertile women who underwent ovulation induction and intra-uterine insemination. J Obstet Gynaecol. 2015;35:707–710.
    1. Liu B., Zhang L., Guo R., Wang W., Duan X., Liu Y. The serum level of C-reactive protein in patients undergoing GnRH agonist protocols for in vitro fertilization cycle. Clin Exp Obstet Gynecol. 2014;41:190–194.
    1. Diba-Bagtash F., Farshbaf-Khalili A., Ghasemzadeh A., Lotz L., Fattahi A., Shahnazi M., et al. Maternal C-reactive protein and in vitro fertilization (IVF) cycles. J Assist Reprod Genet. 2020;37:2635–2641.
    1. Almagor M., Hazav A., Yaffe H. The levels of C-reactive protein in women treated by IVF. Hum Reprod. 2004;19:104–106.
    1. Dimitriadis E., White C.A., Jones R.L., Salamonsen L.A. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update. 2005;11:613–630.
    1. Wang L., Huang X., Li X., Lv F., He X., Pan Y., et al. Efficacy evaluation of low-dose aspirin in IVF/ICSI patients evidence from 13 RCTs: a systematic review and meta-analysis. Medicine (Baltimore) 2017;96
    1. Robinson S., Pemberson P., Laing I., Nardo L.G. Low grade inflammation, as evidenced by basal high sensitivity CRP, is not correlated to outcome measures in IVF. J Assist Reprod Genet. 2008;25:383–388.
    1. Weghofer A., Barad D.H., Darmon S.K., Kushnir V.A., Albertini D.F., Gleicher N. Euploid miscarriage is associated with elevated serum C-reactive protein levels in infertile women: a pilot study. Arch Gynecol Obstet. 2020;301:831–836.
    1. Bower J.K., Lazo M., Juraschek S.P., Selvin E. Within-person variability in high-sensitivity C-reactive protein. Arch Intern Med. 2012;172:1519–1521.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren